Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1452837

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1452837

Global Moist Wound Dressings Market Size, Share, Growth Analysis, By Product(Foams, Hydrocolloids), By Application(Pressure Ulcers, Diabetic Ulcers), By End-user(Hospitals, Homecare) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Moist Wound Dressings market size was valued at USD 4.31 billion in 2022 and is poised to grow from USD 4.53 billion in 2023 to USD 6.80 billion by 2031, growing at a CAGR of 5.2% in the forecast period (2024-2031).

The global market for moist wound dressings demonstrates robust growth, propelled by the rising focus on advanced wound care and the escalating prevalence of chronic wounds like diabetic ulcers and pressure sores. Healthcare professionals are increasingly embracing moist wound dressings due to their capacity to foster an optimal healing environment, prevent infections, and expedite wound recovery. These dressings offer benefits such as enhanced moisture retention, reduced pain, and improved patient comfort. Furthermore, ongoing research and development endeavors are dedicated to enhancing the effectiveness of moist wound dressings through innovative materials and technologies. With the aging population expanding and healthcare infrastructure advancing globally, the demand for efficient wound management solutions is anticipated to drive the market's growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Moist Wound Dressings Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Moist Wound Dressings Market Segmental Analysis

The global moist wound dressings market is segmented on the basis of Product, Application, End user, and region. By Product, the market is segmented into Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Other Dressings. By Application, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical and Traumatic Wounds, Burns, Others. By End user, the market is segmented into Hospitals, Clinics, Home Healthcare. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Moist Wound Dressings Market

A significant factor driving the global moist wound dressings market is the ongoing progress in wound care technologies and materials. Developments in dressing materials, including hydrocolloids, hydrogels, and foam dressings, have resulted in more efficient and adaptable products that foster optimal wound healing environments. Moreover, the incorporation of antimicrobial agents and the creation of smart dressings capable of monitoring wound conditions are enhancing the therapeutic properties of moist wound dressings. These advancements are leading to increased adoption by healthcare professionals and patients, thereby stimulating market growth.

Restraints in the Global Moist Wound Dressings Market

A significant constraint in the global moist wound dressings market is the stringent regulatory landscape governing medical devices and healthcare products. Adhering to diverse regulatory requirements and securing necessary approvals can be a laborious and expensive endeavor for manufacturers. Moreover, evolving regulations and differing standards across various regions can present hurdles for market expansion and product advancement. Negotiating these regulatory obstacles can slow down the pace of innovation and market entry for moist wound dressing products.

Market Trends of the Global Moist Wound Dressings Market

A significant trend in the global moist wound dressings market is the growing focus on integrating bioactive ingredients into these dressings. Manufacturers are exploring the inclusion of substances such as silver, honey, and growth factors to enhance the therapeutic properties of the dressings. These bioactive additives hold promise in expediting wound healing, lowering infection rates, and enhancing overall patient outcomes. As healthcare providers and patients increasingly seek more efficient and comprehensive wound care solutions, moist dressings with bioactive elements are gaining momentum, signaling a noteworthy transition towards advanced and tailored wound management approaches.

Product Code: SQMIG35D2162

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Moist Wound Dressings Market by Product

  • Market Overview
  • Foams
  • Hydrocolloids
  • Semi-Permeable Films
  • Hydrogels
  • Alginates
  • Hydro Fibres and Collagens

Global Moist Wound Dressings Market by Application

  • Market Overview
  • Pressure Ulcers
  • Diabetic Ulcers
  • Burn Wounds
  • Surgical Wounds
  • Traumatic Wounds
  • and Others

Global Moist Wound Dressings Market by End-user

  • Market Overview
  • Hospitals
  • Homecare
  • Clinics
  • and Others

Global Moist Wound Dressings Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • 3M Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Derma Sciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Systagenix Wound Management Ltd (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hollister Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ethicon, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acelity L.P. Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advancis Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Urgo Medical (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • In May 2023, Kane Biotech Inc. (referred to as Kane Biotech) announced that it had gotten 510(k) freedom from the U.S. Food and Drug Administration (FDA) for its coactiv+(TM) Antimicrobial Injury Gel. This clearance covers the management of ulcers (counting diabetic foot and leg ulcers and pressure ulcers), first and severe-degree burns, fractional and full-thickness wounds, enormous surface region wounds, and careful entry points for grown-up populaces.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • In November 2023, Kane Biotech Inc., in collaboration with ProgenaCare Global LLP, disclosed the rebranded revyve(TM) Antimicrobial Injury Gel (previously known as coactiv+(TM) Antimicrobial Injury Gel).
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!